Products found to contain undeclared medicines
|
| |
| Australia: Safety advisory: Robust Extreme capsules |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Robust Extreme capsules and found that the capsules contain the undeclared substance o-propyl vardenafil, an analogue of vardenafil.
Vardenafil taken in combination with other medications can cause serious side effects. Vardenafil may interact with nitrates found in some prescription drugs and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol or heart disease are often prescribed nitrates. Consumers are advised that vardenafil is a prescription-only substance in Australia. The supply of Robust Extreme capsules containing undisclosed vardenafil is illegal. Robust Extreme capsules have not been assessed by us for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
Consumers are advised to stop using Robust Extreme capsules and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/robust-extreme-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Jul 23, 2024
Issued at HKT 16:00
|
| |
